- Covance doubles service capacity to provide integrated discovery, preclinical, and clinical development support for large-scale stability and release programs -
PRINCETON, N.J., June 29 /PRNewswire/ -- Covance Inc. today announced the expansion of the company's analytical and stability services facility in Madison, Wisconsin. The expanded facility doubles service capacity for large-scale, long-term stability and release programs supporting preclinical, clinical, and chemistry, manufacturing, and control (CMC) development of pharmaceutical and animal health products.
"Covance is committed to providing world-class CMC analytical services for our clients to provide the highest quality data and reduce developments timelines," said Henry Hummel, vice president and general manager, Madison sites, Covance. "Together with our integrated discovery, preclinical, and clinical service offerings and dedicated program management team, we can now offer CMC analytical services as part of an entire molecule development program."
The expanded facility includes upgraded stability chambers equipped with high-density tracked shelving to significantly increase pharmaceutical analysis service capacity and utilization. Designed to house up to ten walk-in chambers and several reach-in chambers, the facility also provides space to accommodate future expansion.
As a leading contract service provider to the global pharmaceutical and animal health industry, Covance offers a comprehensive portfolio of CMC analytical services, including analytical method development, validation and transfer, stability, and product release testing. Covance also offers expertise in inhalation, extractables and leachables, and nitrosamine testing.
About Covance
Covance, with headquarters in Princeton, New Jersey
'/>"/>
| SOURCE Covance Inc. Copyright©2009 PR Newswire. All rights reserved |